Services:

Strategic Advisory

Successful commercialization in the life sciences industry today requires the ability to articulate, set and execute a vision for the long term.

Home / Services / Strategic Advisory

At the heart of all we do, we advise. We understand how important every decision is along the continuum of getting a product to market, which in the life sciences industry can translate into getting a life-changing or lifesaving treatment to a patient. We have the experts and experience to bring in the right data, analysis and evidence to provide insights and recommendations to support your decisions.

We offer strategic advice on all aspects of commercializing a brand.

Advisory Offerings

  • Brand & Marketing Strategy

    Achieving a brand’s full potential takes a depth of focus, a firm grasp on the nuances of the market and the flexibility to work with anything Brand touches—a unique set of capabilities Trinity’s Brand & Marketing Excellence COE provides to clients.

    The most successful brands meaningfully differentiate themselves among the competition with cohesive strategy driven by data and informed by insights.

    Trinity supports global/local affiliate marketing and brand strategy across all phases of the product lifecycle:

    • Early insights and brand strategy foundation
    • Launch readiness review, go-to-market (GTM) strategy
    • Annual brand planning, commercial performance and operational activities
    • Late lifecycle brand optimization and LOE strategy development

    Trinity’s Brand & Marketing Excellence offerings include:

    • Brand Strategy Development
    • Global Strategic Alignment
    • Functional/Tactical Planning
    • Strategic Issue Deep Dives
    • Brand Health Audits
    • Brand Health Assessment
    • Agile Brand Management
    • And more…
  • Business Development Support

    Business Development Support has been a core part of Trinity’s offerings for decades. Customers select Trinity because of our data-driven approach, our experience in assessing fit within the customer portfolio and our ability to articulate a thoughtful business case for—or against—an opportunity. Our approach balances key considerations by leveraging therapeutic-area knowledge and targeted analytics to deliver recommendations customers can trust.

    Trinity offers a range of support tailored to the stage of diligence and the time requirements, including identification and prioritization of target assets, therapeutic-area prioritization, country-specific payer insights and market landscapes. All our opportunity assessments include secondary research on the market and an Excel-based forecast for scenario planning, including NPV and cost analysis. Additional modules can be added to conduct primary market research or claims research or to provide a comprehensive view of the market access landscape. We also provide assistance with commercial due diligence, term-sheet analysis and development, assistance with investor pitch decks, partnering and deal support.

  • Competitive Intelligence

    Providing curated, informed and accurate insights on competitive and market environments across the life sciences industry

  • Corporate Strategy

    Trinity’s Corporate Strategy offerings help companies identify their aspirational goals and then develop the strategic roadmap to realize them. Over the years, we have completed thousands of projects across all aspects of corporate strategy with industry leaders, C-Suite executives, and corporate boards to help inform some of the most critical decisions they make for their businesses.

    The Trinity approach is designed to drive commercial decisions forward while ensuring growth and profitability. We can help maximize current assets and can assist with R&D prioritization, mergers and acquisition (M&A)/licensing strategy, and decisions about whether to partner or build-out commercial organizations.

  • Franchise & Portfolio Strategy

    Trinity’s Franchise & Portfolio Strategy offerings empower our customers to enter or expand their footprint within a market. With multiple strategic options and limited resources to evaluate their choices, companies turn to Trinity for our ability to grasp the critical market factors with ease and our skill in quickly and creatively identifying the best opportunities. Our goal is to create a clear understanding of key decision and trigger points around each opportunity so the franchise strategy can be updated as assets of interest move through development.

    Our integrated, evidence-based approach helps clients make important decisions at the brand, business, and corporate levels, including:

    • Corporate growth strategy: buy, build, or partner
    • Business-unit and therapeutic-area assessments
    • Identification of new business opportunities
    • Resource allocation and investment decision support
    • In-depth market and competitive intelligence
    • Development and optimization of new products
    • Benchmarking and case studies
    • Strategic options/scenario analysis
  • New Product Planning

    Successfully bringing a new product to market requires strategy built on an effective planning foundation but also the insight necessary to adjust the plan as circumstances change.

    Trinity’s Strategic Product Planning offerings address the unique needs of clients setting up their brand for long-term success. Our expertise in laying the foundation for commercial understanding, providing input into the development plan, and articulating the points of uncertainty gives our customers a reliable partner every step of the way.

    With deep verticals in primary market research, data analytics, and strategic forecasting, our uniquely integrated approach to strategic and new-product planning combines best-in-class methods and products with advisory services to ensure that strategy is central from the early stages of product development.

    New Product Planning
    Trinity’s New Product Planning projects help our clients develop products that will resonate in the market. Our suite of offerings identifies the needs of market stakeholders and designs strategies to optimize the product, with cost-effective approaches to ensure the appropriate level of rigor for each stage of development. New project planning provides a solid foundation upon which early commercialization teams can build as the product proceeds through development.

    Strategic Forecasting
    Forecasting is the bedrock on which Trinity was founded and continues to be our most frequently requested project type each year. Our expertise is developing an appropriate framework to value early-stage products with limited information and risk assessment tools necessary to account for the uncertainty inherent in early-stage forecasting.

    With superior industry knowledge, accessibility, transparency, and close communication with multiple internal stakeholder groups, Trinity excels at developing assumptions that are well supported with data, analogs, and aligned with our customers’ teams.

    Whether customers need a stand-alone strategic forecast or leverage best-in-class methodologies to populate their assumptions, Trinity can support all early commercialization forecasting needs.

  • Patient Centricity

    Listening to the Voice of the Patient all the way from R&D through launch and beyond.

    For Trinity, Patient Centricity means integrating the Voice of the Patient across the entire product lifecycle to keep patients’ wants and needs at the center.

  • Patient Services

    Developing and executing high-impact Patient Support Services (PSS) is of critical importance as manufacturers strive to create patient-centric customer experiences.

    Trinity’s Patient Services Center of Excellence provides advisory services powered by a dedicated team of experts with access to differentiated patient insights, proprietary benchmarking data, advanced analytics and tracking tools.

Center of Excellence

Cell and Gene Therapy

Cell and Gene Therapy

Cell and gene therapies (CGTs) represent the next major breakthrough in the development of innovative treatments for severe diseases, with the possibility to address the root causes of disease and provide lasting clinical value, and in some cases, a cure.

Learn More

Latest Strategic Advisory Intelligence

Meet Our Strategic Advisory Experts

If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.